查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1492670

Ciclanderate 市场：按配方、应用、分销管道划分 - 全球预测 2024-2030

Cyclandelate Market by Formulation (Injectable, Oral), Application (Cerebral Vascular Insufficiency, Peripheral Vascular Disorder), Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年Ciclanderate市场规模为6.4674亿美元，预计2024年将达到6.7733亿美元，2030年将达到9.0449亿美元，复合年增长率为4.90%。

西克兰德酯是一种主要用于治疗与血液循环不良相关的疾病的药物。西兰酸可以放鬆血管平滑肌，增加血流。透过扩张血管，可以缓解与血管疾病相关的症状，如痉挛、疼痛、手脚冰冷等。西克兰德酯通常口服，其使用和剂量应在医疗保健专业人员的指导下进行。由于生活习惯和人口老化，与血液循环不良相关的疾病不断增加，对香菜酸等有效治疗药物的需求不断增加。改善医疗基础设施和增加医疗成本可能会导致人们广泛获得和采用包括香菜在内的治疗方法。然而，严格的药物核准和市场准入法规可能会造成重大障碍，延长开发时间并增加成本。此外，药物研究和开发的进步可能会扩大香菜酯的用途或提高其功效和安全性，从而促进市场成长。药物传递方面的创新，例如控制释放製剂，有可能改善患者的治疗效果和对含环化合物治疗的依从性。

主要市场统计
基准年[2023] 64674万美元
预测年份 [2024] 67733万美元
预测年份 [2030] 90449万美元
复合年增长率（%） 4.90%

区域洞察

在美国和加拿大，香菜的消费很大程度上与人们对周围血管疾病的认识增强和人口老化同时发生。这些因素导致了对有效的血管扩张剂治疗的需求，例如西兰德酯，以缓解脑血管供血不足和周边动脉疾病等症状。该地区的客户行为反映了对受临床研究支持并获得美国FDA 等监管机构核准的产品的偏好。欧盟国家拥有强大的医疗保健和药品监管体系，由欧洲药品管理局 (EMA) 和其他机构管理。该地区老年人口普遍较多，医药产业发展完善，注重药品安全性和有效性，因此对香菜的需求稳定。中东和非洲地区是一个医疗保健系统多样化的市场。高所得国家已经建立了与西方标准相当的卫生系统，包括获得含有香菜酸盐的药物。然而，在非洲部分地区，经济限制和后勤挑战可能限制获得基本药物。亚太地区是一个经济和医疗保健领域快速成长的地区。中国和印度正在对医疗基础设施和当地药品生产进行大量投资，降低药品价格，让更多人更容易获得药品。日本以其先进的研究能力而闻名，不断探索新的治疗可能性和环己烷等药物的输送系统。

FPNV定位矩阵

FPNV 定位矩阵对于评估 Ciclanderate 市场中的供应商定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对 Ciclanderate 市场供应商的当前状态进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在 Ciclanderate 市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球週边血管疾病盛行率增加
      • 改善投资以加强医疗基础设施
    • 抑制因素
      • 原料成本波动
    • 机会
      • 药物输送系统的创新和环烷酸盐改进配方的开发
      • 政府核准生产和销售香荠菜
    • 任务
      • 替代药物的可用性和与西兰德酯相关的副作用
  • 市场区隔分析
    • 剂型：由于剂量控制和即时治疗效果，注射用环烷酸盐变得越来越重要
    • 分销管道：医院药房可提供即时获取，在急诊环境中至关重要。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 西兰德市场：依配方分类

  • 注射
  • 口服

第七章 西兰德市场：依应用分类

  • 脑血管供血不足
  • 週边血管疾病

第 8 章 Ciklanderat 市场：按分销管道

  • 医院药房
  • 网路药房

第九章 美洲的环烷酸盐市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太Ciclanderat市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲/中东/非洲西兰德市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 市场占有率分析（2023）
  • FPNV定位矩阵（2023）
  • 竞争场景分析
    • 加拿大政府宣布投资 2,600 万加元加强综合卫生系统
    • 政府对印度製药和医疗设备产业的大量投资
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-5D693B46C72B

[194 Pages Report] The Cyclandelate Market size was estimated at USD 646.74 million in 2023 and expected to reach USD 677.33 million in 2024, at a CAGR 4.90% to reach USD 904.49 million by 2030.

Cyclandelate is a medication mainly used to treat conditions related to poor blood circulation. Cyclandelate relaxes smooth muscles in blood vessels, which can help to increase blood flow. This widening of blood vessels can alleviate symptoms associated with vascular disorders, such as cramps, pain, and feeling cold in the limbs. Cyclandelate is typically taken orally, and its usage and dosage should be guided by a healthcare professional's advice. Increasing incidences of diseases related to poor blood circulation due to lifestyle factors and an aging population drive demand for effective treatments such as Cyclandelate. Enhanced healthcare infrastructure and increased healthcare spending can lead to broader accessibility and adoption of treatments involving Cyclandelate. However, stringent regulations in drug approval and market entry for pharmaceuticals can pose a significant barrier, extending development timelines and increasing costs. Furthermore, advances in pharmaceutical R&D may expand the applications of Cyclandelate or improve its efficacy and safety profile, contributing to market growth. Innovations in medication deliveries, such as controlled-release formulations, could improve patient outcomes and adherence to therapy involving Cyclandelate.

KEY MARKET STATISTICS
Base Year [2023] USD 646.74 million
Estimated Year [2024] USD 677.33 million
Forecast Year [2030] USD 904.49 million
CAGR (%) 4.90%

Regional Insights

In the United States and Canada, the consumption of cyclandelate largely aligns with the increasing awareness of peripheral vascular diseases and the aging population. These factors contribute to the demand for effective vasodilatory treatments, such as cyclandelate, which helps alleviate conditions such as cerebral vascular insufficiency and peripheral artery disease. Customer behavior in this region reflects a preference for products that are endorsed by clinical research and approved by regulatory bodies like the FDA in the USA. EU countries exhibit a strong system for healthcare and medication regulation, managed by entities including the European Medicines Agency (EMA). The region has a consistent demand for cyclandelate, driven by a generally older population and a well-established pharmaceutical sector emphasizing drug safety and efficacy. The MEA region presents a diverse market with varying access to healthcare systems. Higher-income countries have well-established healthcare systems comparable to Western standards, including access to medications, including cyclandelate. However, in parts of Africa, access to essential medications can be limited by economic constraints and logistical challenges. Asia Pacific is a rapidly growing region in terms of both economy and healthcare advancements. China and India are investing significantly in healthcare infrastructure and local pharmaceutical manufacturing, driving down the cost of medication and making it more accessible to the wider population. Japan, known for its advanced research capabilities, continues to explore new therapeutic potentials and delivery systems for drugs such as cyclandelate.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Cyclandelate Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of peripheral vascular diseases worldwide
      • Improved investments for enhancing healthcare infrastructures
    • Market Restraints
      • Fluctuation in costs of raw materials
    • Market Opportunities
      • Innovation in drug delivery systems and development of improved formulations of cyclandelate
      • Government approvals for production and marketing of cyclandelate
    • Market Challenges
      • Availability of alternative drugs and side effects associated with cyclandelate
  • Market Segmentation Analysis
    • Formulation: Growing significance of injectable cyclandelate due to controlled dosages and immediate therapeutic effects
    • Distribution Channel: Hospital pharmacies essential for immediate access and crucial for acute care settings
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cyclandelate Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cyclandelate Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Government of Canada Announces CAD 26 Million Investment to Enhance Integrated Health Care Systems

The Government of Canada, in collaboration with several partners, announced a significant investment exceeding CAD 26 million aimed at improving integrated healthcare services across the nation. This funding supports initiatives designed to streamline healthcare delivery, fostering more coordinated and patient-centered services. This investment aims to enhance efficiency in healthcare systems and targets the improvement of patient outcomes, focusing on seamless integration between different healthcare providers to ensure that Canadians receive timely and effective care. [Published On: 2023-10-20]

Significant Government Investment in India's Pharma and Medical Device Sectors

The Indian government has approved a substantial investment of INR 6,000 crore under the Production Linked Incentive (PLI) scheme aimed at bolstering the pharmaceutical and medical devices sectors, as announced by the Home Minister. This strategic move is designed to enhance self-reliance in critical healthcare segments by incentivizing domestic production, reducing import dependencies, and accelerating the development of high-quality medical products. [Published On: 2023-09-30]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cyclandelate Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cyclandelate Market, highlighting leading vendors and their innovative profiles. These include Biosynth, Chemwill Asia co.,Ltd, Jinan Jinda Pharmaceutical Chemistry Co.,Ltd, LGC Limited, Merck KGaA, RayBiotech, Inc., SAGECHEM, Taj Pharmaceuticals Limited, Tebubio, Thermo Fisher Scientific Inc., Tokyo Chemical Industry, and Vial Health Technology, Inc..

Market Segmentation & Coverage

This research report categorizes the Cyclandelate Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Formulation
    • Injectable
    • Oral
  • Application
    • Cerebral Vascular Insufficiency
    • Peripheral Vascular Disorder
  • Distribution Channel
    • Hospitals Pharmacies
    • Online Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of peripheral vascular diseases worldwide
      • 5.1.1.2. Improved investments for enhancing healthcare infrastructures
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuation in costs of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovation in drug delivery systems and development of improved formulations of cyclandelate
      • 5.1.3.2. Government approvals for production and marketing of cyclandelate
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative drugs and side effects associated with cyclandelate
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Formulation: Growing significance of injectable cyclandelate due to controlled dosages and immediate therapeutic effects
    • 5.2.2. Distribution Channel: Hospital pharmacies essential for immediate access and crucial for acute care settings
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cyclandelate Market, by Formulation

  • 6.1. Introduction
  • 6.2. Injectable
  • 6.3. Oral

7. Cyclandelate Market, by Application

  • 7.1. Introduction
  • 7.2. Cerebral Vascular Insufficiency
  • 7.3. Peripheral Vascular Disorder

8. Cyclandelate Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospitals Pharmacies
  • 8.3. Online Pharmacies

9. Americas Cyclandelate Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cyclandelate Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cyclandelate Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Government of Canada Announces CAD 26 Million Investment to Enhance Integrated Health Care Systems
    • 12.3.2. Significant Government Investment in India's Pharma and Medical Device Sectors
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CYCLANDELATE MARKET RESEARCH PROCESS
  • FIGURE 2. CYCLANDELATE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CYCLANDELATE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CYCLANDELATE MARKET DYNAMICS
  • FIGURE 7. GLOBAL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CYCLANDELATE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CYCLANDELATE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CYCLANDELATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CYCLANDELATE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CYCLANDELATE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CYCLANDELATE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CYCLANDELATE MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CYCLANDELATE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CYCLANDELATE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CYCLANDELATE MARKET SIZE, BY CEREBRAL VASCULAR INSUFFICIENCY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CYCLANDELATE MARKET SIZE, BY CEREBRAL VASCULAR INSUFFICIENCY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CYCLANDELATE MARKET SIZE, BY PERIPHERAL VASCULAR DISORDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CYCLANDELATE MARKET SIZE, BY PERIPHERAL VASCULAR DISORDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 34. ARGENTINA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 39. BRAZIL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 40. BRAZIL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 45. CANADA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 46. CANADA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. MEXICO CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 52. MEXICO CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 58. UNITED STATES CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 74. AUSTRALIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 79. CHINA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 80. CHINA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 85. INDIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 86. INDIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 91. INDONESIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 92. INDONESIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 97. JAPAN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 98. JAPAN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 104. MALAYSIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 110. PHILIPPINES CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 116. SINGAPORE CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 122. SOUTH KOREA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. TAIWAN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 128. TAIWAN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 133. THAILAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 134. THAILAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 139. VIETNAM CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 140. VIETNAM CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 153. DENMARK CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 154. DENMARK CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 159. EGYPT CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 160. EGYPT CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 165. FINLAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 166. FINLAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 171. FRANCE CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 172. FRANCE CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 177. GERMANY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 178. GERMANY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. ISRAEL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 184. ISRAEL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 189. ITALY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 190. ITALY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 196. NETHERLANDS CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 201. NIGERIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 202. NIGERIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. NORWAY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 208. NORWAY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 213. POLAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 214. POLAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 219. QATAR CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 220. QATAR CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. RUSSIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 226. RUSSIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 243. SPAIN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 244. SPAIN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 249. SWEDEN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 250. SWEDEN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 256. SWITZERLAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 261. TURKEY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 262. TURKEY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 279. CYCLANDELATE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. CYCLANDELATE MARKET, FPNV POSITIONING MATRIX, 2023